Key result
COVID-19 pandemic linked to ~30% worldwide drop in NSTE-ACS hospital admissions.
Why the study?
How COVID-19 impacted non-ST-segment elevation acute coronary syndromes has been the subject of controversial reports.
Does the COVID-19 pandemic reduce hospital admissions for non-ST-elevation acute coronary syndromes (NSTACS) compared to reference periods?
Meta-Analysis (n=553,038)
Yes
Does the COVID-19 pandemic reduce hospital admissions for non-ST-elevation acute coronary syndromes (NSTACS) compared to reference periods?
During the peak of the COVID-19 pandemic, hospitalizations for non-ST-elevation acute coronary syndromes decreased significantly by an average of 30% worldwide, though with substantial regional heterogeneity.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to possible missed NSTACS cases in future crises; confirms global reduction via pooled observational data with regional heterogeneity.
BACKGROUND: How coronavirus disease 2019 (COVID-19) impacted non-ST-segment elevation acute coronary syndromes (NSTACS) is an object of controversial reports. AIM: To systematically review studies reporting NSTACS hospitalizations during the COVID-19 pandemic, and analyse whether differences in COVID-19 epidemiology, methodology of report, or public health-related factors could contribute to discrepant findings. METHODS: Comprehensive search (Medline, Embase, Scopus, Web of Science, Cochrane Register), of studies reporting NSTACS hospitalizations during the COVID-19 pandemic compared with a reference period, following Preferred Reporting Items for Systematic Reviews and Meta-analysis guidelines. Data were independently extracted by multiple investigators and pooled using a random-effects model. Health-related metrics were from publicly available sources, and analysed through multiple meta-regression modelling. RESULTS: We retrieved 102 articles (553 038 NSTACS cases, 40 countries). During peak COVID-19 pandemic, overall incidence rate ratio (IRR) of NSTACS hospitalizations over reference period decreased (0.70, 95% confidence interval (CI) 0.66-0.75; P < 0.00001). Significant heterogeneity was detected among studies (I2 = 98%; P < 0.00001). Importantly, wide variations were observed among, and within, countries. No significant differences were observed by study quality, whereas comparing different periods within 2020 resulted in greater decrease (IRR: 0.61; CI: 0.53-0.71) than comparing 2020 vs. previous years (IRR: 0.74; CI 0.69-0.79). Among many variables, major predictors of heterogeneity were severe acute respiratory syndrome coronavirus 2 reproduction rate/country, number of hospitals queried, and reference period length; country stringency index and socio-economical indicators did not contribute significantly. CONCLUSIONS: During the COVID-19 pandemic, NSTACS hospitalizations decreased significantly worldwide. However, substantial heterogeneity emerged among countries, and within the same country. Factors linked to public health management, but also to methodologies to collect results may have contributed to this heterogeneity. TRIAL REGISTRATION: The protocol was registered in the PROSPERO International Prospective Register of Systematic Reviews (ID: CRD42022308159).
No takes yet. Share an insight, caveat, or question.
Sofi et al. (2023) conducted a meta-analysis in Non-ST-elevation acute coronary syndromes (NSTACS) (n=553,038). COVID-19 pandemic vs. Pre-pandemic or non-peak reference period was evaluated on Incidence rate ratio (IRR) of NSTACS hospitalizations (IRR 0.70, 95% CI 0.66-0.75, p=<0.00001). The COVID-19 pandemic was associated with a 30% worldwide decrease in hospital admissions for non-ST-elevation acute coronary syndromes compared to reference periods.
Synapse has enriched 10 related papers. Consider them for comparative context: